Anti-SARS-CoV-2 Antibody Kinetics up to 6 months of follow-up: Result from a Nation-wide Population-based, Age Stratified Sero-Epidemiological Prospective Cohort Study in India
Preprint
Abstract
Repeated serological testing tells about the change in the overall infection in a community. This study aimed to evaluate changes in antibody prevalence and kinetics in a closed cohort over six months in different sub-populations in India. The study included 10,000 participants from rural and urban areas in five states and measured SARS-CoV-2 antibodies in serum in three follow-up rounds. The overall seroprevalence increased from 73.9% in round one to 90.7% in round two and 92.9% in round three. Among seropositive rural participants in round one, 98.2% remained positive in round two, and this percentage remained stable in urban and tribal areas in round three. The results showed high antibody prevalence that increased over time and was not different based on area, age group, or sex. Vaccinated individuals had higher antibody prevalence, and nearly all participants had antibody positivity for up to six months.Keywords
All Related Versions
- Published version: PLOS ONE, 18 (12), e0287807.
This publication has 10 references indexed in Scilit:
- SARS-CoV-2 Seroprevalence in Delhi, India, During September-October 2021: A Population-Based Seroepidemiological StudyCureus, 2022
- Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in children and adolescents in Delhi, India, from January to October 2021: a repeated cross-sectional analysisOsong Public Health and Research Perspectives, 2022
- Third Wave of the COVID-19 Pandemic: Prominence of Initial Public Health InterferenceInfectious Disorders - Drug Targets, 2022
- Living with endemic COVID-19Public Health, 2022
- SARS-CoV-2 seroprevalence in Delhi, India - September-October 2021 – a population based seroepidemiological studymedRxiv, 2021
- Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: A population-based cross-sectional studyPLOS Medicine, 2021
- Global COVID-19 Pandemic Waves: Limited Lessons Learned Worldwide over the Past YearEngineering, 2021
- COVID‐19 vaccination strategies and policies in India: The need for further re‐evaluation is a pressing priorityThe International Journal of Health Planning and Management, 2021
- Persistence of Anti-SARS-CoV-2 Antibodies Six Months after Infection in an Outbreak with Five Hundred COVID-19 Cases in Borriana (Spain): A Prospective Cohort StudyCOVID, 2021
- Differences between First wave and Second wave of COVID-19 in IndiaDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021